Skip to main content
Premium Trial:

Request an Annual Quote

Genometrix CEO Robert Ellis Appointed Affymetrix Product Development and Quality VP: New General Counsel and CFO Named

NEW YORK, July 25 - Affymetrix has named Robert Ellis, who stepped down as CEO of Genometrix just before the company closed its doors June 25, to the position of vice president, product development and quality. 

The company also announced that Barbara Caulfield would be the new vice president and general counsel, replacing Vern Norviel, who has become the new general counsel of subsidiary Perlegen.

Additionally, Gregory Schiffman will assume the role of chief financial officer beginning August 10, while current CFO Edward Hurwitz will take on a new role as senior vice president of corporate strategy and new ventures, the company said.

“This is a time of growth for Affymetrix and these management changes reflect our commitment to business expansion,” said Affymetrix CEO Stephen Fodor during the company’s second-quarter conference call.

In addition to his experience at Genometrix, of the Woodlands, Texas, Ellis has served as Applied Biosystems’ head of genetic analysis and nucleic acid synthesis, and was the company’s Far East vice president and general manager when Applied Biosystems was a division of Perkin Elmer. Ellis, who holds a B.A. from Hartwick College in New York, also worked for nine years in the scientific instrument division of Hewlett-Packard. 

Caulfield joins Affymetrix from the law firm of Orrick, Herrington & Sutcliffe, where she was a partner and represented the company in its patent disputes with Incyte and Oxford Gene Technology. She has also represented Microsoft, Apple Computer, Mobil Oil, and Hoffman-LaRoche in patent disputes. She also formerly served as U.S. District Judge for the Northern District of California from 1991 until 1994. 

Schiffman, who began working at Affymetrix earlier in the year as vice president of finance and administration, previously served vice president and controller of Applied Biosystems, and has 16 years of finance experience at Hewlett Packard and IBM. 

Hurwitz, who has served as Affymetrix CFO since 1997, “ is taking on a new role in order to expand the opportunities for our technology and Affymetrix,” Fodor said.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.